3 simple steps to lose weight as fast as possible. Read now

Saccharomyces Boulardii: Benefits, Uses, and How It's Different

Saccharomyces boulardii is a beneficial yeast — not a bacteria — with strong evidence for preventing antibiotic-associated diarrhea, traveler's diarrhea, and certain GI infections.

Evidence-based
This article is based on scientific evidence, written by experts, and fact-checked by experts.
We look at both sides of the argument and strive to be objective, unbiased, and honest.
Saccharomyces Boulardii: Benefits and How to Use It
Last updated on May 10, 2026, and last reviewed by an expert on May 10, 2026.

Most probiotics are bacteria. Saccharomyces boulardii is different — it’s a non-pathogenic yeast that survives stomach acid, isn’t affected by antibiotics (a major advantage), and has stronger clinical evidence for several conditions than most bacterial probiotics.

Saccharomyces Boulardii: Benefits and How to Use It

For one specific use — preventing antibiotic-associated diarrhea, especially in children — it’s one of the best-studied probiotics available, with evidence levels above most popular Lactobacillus and Bifidobacterium strains.

Here’s what S. boulardii actually does, when to use it, and how to take it well.

What it is

Saccharomyces boulardii is a strain of yeast originally isolated from lychee and mangosteen fruits in Indochina in the 1920s. The most-studied form is the CNCM I-745 strain, sold under brand names like Florastor.

Key features that distinguish it from bacterial probiotics:

These properties make S. boulardii uniquely useful in scenarios where bacterial probiotics struggle.

What the research strongly supports

1. Antibiotic-associated diarrhea (AAD) prevention — strongest evidence

Antibiotics disrupt the gut microbiome. About 5–25% of adults and even more children develop diarrhea during or after antibiotic courses. S. boulardii dramatically reduces this risk.

A 2019 Cochrane systematic review of 33 studies in 6,352 children showed probiotics reduced AAD incidence from 19% in the control group to 8% in the probiotic group — a number-needed-to-treat (NNT) of 9 to prevent one case of AAD. Higher-dose probiotics (≥5 billion CFU/day) were more effective than lower doses, with an NNT of 6.1 S. boulardii and Lactobacillus rhamnosus were specifically called out as having strong evidence.

For adults, similar evidence shows S. boulardii roughly halves AAD risk.

2. Clostridioides difficile (C. diff) prevention and recurrence

S. boulardii has solid evidence for preventing C. diff recurrence — a serious complication after antibiotic-induced gut disruption. Particularly studied as an adjunct to standard treatment in patients with recurrent C. diff infections.

Less effective alone for active C. diff than as prevention or adjunct.

When’s the Best Time to Take Probiotics? Expert Insights
Suggested read: When’s the Best Time to Take Probiotics? Expert Insights

3. Traveler’s diarrhea

Multiple trials show S. boulardii started 5–7 days before travel and continued through the trip reduces traveler’s diarrhea risk by roughly 30%. Not a complete prevention, but a meaningful reduction.

4. Helicobacter pylori treatment

When added to standard H. pylori antibiotic regimens, S. boulardii reduces side effects and may improve eradication rates. Used as an adjunct in many guidelines.

5. Acute infectious diarrhea (children)

Reduces duration of acute diarrhea episodes by approximately 1 day in pediatric trials. Particularly evidence-based for rotavirus diarrhea and acute gastroenteritis.

Where evidence is moderate or mixed

Inflammatory bowel disease (IBD)

Some evidence for ulcerative colitis as adjunct treatment; mixed for Crohn’s disease. Not a primary therapy.

Irritable bowel syndrome (IBS)

Modest evidence for symptom improvement, particularly diarrhea-predominant IBS (IBS-D).

Acne and skin conditions

Theoretical via gut-skin axis; clinical evidence sparse.

Autoimmune conditions

Theoretical interest; clinical evidence preliminary.

Where evidence is weak or absent

Don’t take S. boulardii for these — it has specific uses, not broad ones.

How to use it

Standard dose

Timing during antibiotics

This is the unique advantage:

Unlike bacterial probiotics, you don’t need to space S. boulardii away from antibiotic doses — it’s antibiotic-resistant.

Suggested read: CoQ10 Benefits: What Science Shows About Coenzyme Q10

Timing for prevention

For traveler’s diarrhea:

For C. diff prevention in high-risk patients:

With or without food

Either works. Some clinicians recommend with food for slightly better tolerance.

Forms available

Refrigeration isn’t required for most products, unlike many bacterial probiotics.

Who should consider it

Strong candidates:

Who should be cautious

Severely immunocompromised

S. boulardii is normally non-pathogenic, but rare cases of fungemia (yeast in the bloodstream) have been reported in:

For these populations, consult a doctor before using.

Yeast allergies

Rare but possible. Severe yeast allergies are a contraindication.

Pregnancy

Generally considered safe at standard doses; consult provider.

Critical illness

Some hospitals avoid all probiotics in ICU patients due to bloodstream infection risk.

Suggested read: 5 Probiotic Side Effects and How to Reduce Them

Side effects

For most users, S. boulardii is very well-tolerated. Common minor effects:

Serious effects are rare and usually limited to immunocompromised populations as noted above.

How to choose a quality product

Look for:

Avoid:

Cost

$15–30/month for a quality product taken daily. Less if used only during antibiotic courses or travel.

S. boulardii vs. other probiotics

When does each make sense?

ScenarioBest probiotic
During antibioticsS. boulardii (antibiotic-resistant)
C. diff preventionS. boulardii
Traveler’s diarrheaS. boulardii
General gut healthMulti-strain bacterial probiotic
Vaginal/UTI supportL. rhamnosus GR-1 + L. reuteri RC-14 (see probiotics for women)
IBS supportSpecific bacterial strains (Bifidobacterium infantis, etc.)
Acute infectious diarrhea (kids)S. boulardii or L. rhamnosus GG

For broader probiotic context, see probiotics and health benefits of probiotics.

Common questions

Can I take it with bacterial probiotics? Yes — different mechanisms. Some people stack them, particularly during antibiotic courses.

How long until it works? For diarrhea prevention: starts working within 1–2 days. For C. diff prevention: protects throughout treatment course.

Will it permanently change my gut? No — S. boulardii doesn’t colonize. It passes through over 3–5 days after stopping. This is a feature for some uses.

Is it safe long-term? For most people, yes. Years of use have been studied without significant issues. The exceptions are immunocompromised populations.

Should I take it daily or only when needed? Most evidence supports situational use (during antibiotics, before travel, during C. diff treatment) rather than continuous daily use. For chronic GI issues, daily use under medical guidance.

Can children take it? Yes — substantial pediatric evidence. Pediatric formulations available.

Is it the same as nutritional yeast? No — completely different organism. Nutritional yeast (S. cerevisiae) doesn’t have the same effects.

Will it interact with my medications? Generally minimal interactions. Antibiotic-resistant nature means it doesn’t interact with antibiotics. Discuss with provider if on immunosuppressants.

Suggested read: Cranberry Pills: Benefits, Side Effects, Dosage Guide

Bottom line

Saccharomyces boulardii is one of the best-evidenced probiotics for specific scenarios: antibiotic-associated diarrhea, C. difficile prevention, traveler’s diarrhea, and acute infectious diarrhea in children. Its yeast-not-bacteria identity and antibiotic resistance make it uniquely useful during antibiotic courses. Take 5 billion CFU/day with a quality product, start with antibiotics or 5–7 days before travel, continue for 1–2 weeks after the trigger ends. Excellent safety profile in healthy adults; consult a doctor if severely immunocompromised. For these specific uses, it outperforms most bacterial probiotics.


  1. Guo Q, Goldenberg JZ, Humphrey C, El Dib R, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;4(4):CD004827. PubMed ↩︎

Share this article: Facebook Pinterest WhatsApp Twitter / X Email
Share

More articles you might like

People who are reading “Saccharomyces Boulardii: Benefits and How to Use It” also love these articles:

Topics

Browse all articles